Henk van Middendorp

Renapta BV develops medical systems for the benefit of people with kidney impairment. The firm works with an international panel of nephrologists, addresses this urgent medical need by developing an extracorporeal device that will be used in conjunction with hemodialysis and the device separates plasma from blood and then selectively captures uremic toxins from the plasma with the use of aptamers. The company was founded by Henk van Middendorp in 2010 and is headquartered in Nijkerk, the Netherlands.

Schretlen & Co. (SC) is the private banking subsidiary of Coöperatieve Rabobank UA in The Netherlands. Founded in 1911, SC is headquartered in Amsterdam and specializes in private banking, financial advisory and planning services, as well as asset management for medium-sized institutional clients and high-net worth individuals.